{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-342384","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2026-08-10T20:10:18+00:00","discovered_at":"2026-08-10T20:11:00.355851+00:00","generated_at":"2026-08-10T20:11:20.434809+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Definitive Healthcare Q2 revenue down 9% to $55.2M; adjusted profit beats guidance","bullets":["Q2 2026 revenue $55.2M, down 9% from $60.8M YoY; net loss improved to $(7.5)M from $(9.3)M.","Adjusted EBITDA $14.6M (26% margin) vs $18.7M (31% margin) in Q2 2025; adjusted net income $7.5M.","Operating cash flow $11.5M; unlevered free cash flow $11.6M; launched AI platform Turbo.","Q3 2026 guidance: revenue $54.0-55.0M, adjusted EBITDA $13.5-14.5M; FY26 revenue $220-222M, adj EPS $0.18-0.20.","Second consecutive quarter of YoY net dollar retention improvement; six-figure win-back deal."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-342384","json":"https://secwatch.observer/filing/0001193125-26-342384.json","markdown":"https://secwatch.observer/filing/0001193125-26-342384.md","text":"https://secwatch.observer/filing/0001193125-26-342384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526342384/0001193125-26-342384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526342384/dh-20260810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T20:11:20.434809+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}